Trial Profile
An Open-label, Cross Over Study, to Assess the Interactions of Pantoprazole (Proton Pump Inhibitor) With Oral Cladribine Administered in Subjects With Multiple Sclerosis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Pantoprazole (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors EMD Serono
- 10 Jan 2012 Primary endpoints identified as reported by ClinicalTrials.gov.
- 21 Jul 2009 New trial record